Unknown

Dataset Information

0

Functionally enhanced siRNA targeting TNF? attenuates DSS-induced colitis and TLR-mediated immunostimulation in mice.


ABSTRACT: Tumor necrosis factor (TNF?) is a proinflammatory cytokine involved in the pathogenesis of inflammatory bowel disease (IBD). Although TNF? has been extensively targeted using systemic drugs, the use of antisense and small interfering RNA (siRNA) to drive down its expression at the site of inflammation should provide important advantages. In this study, native and chemically modified siRNA against TNF? was developed and characterized using a murine model of IBD. siRNA with 2'-O-methyl and propanediol modifications (siTNF-OMe-P) were resistant to nuclease degradation and provided better silencing efficacy in vitro as compared to unmodified siRNA. Every modification reduced nonspecific Toll-like receptor (TLR)-mediated immunomodulation in human peripheral blood mononuclear cells (PBMC) cells. Intrarectal administration of siTNF-OMe-P significantly ameliorated the clinical endpoints and histopathological severity in 5% dextran sulphate sodium (DSS)-treated mice as compared to unmodified and other chemically modified siRNAs. Differential gene expression assessed in siTNF-OMe-P-treated animals correlated with improved colon integrity and reduced TLR activation as compared to all treatment groups. All in all, this study demonstrates that propanediol and 2'-O-methyl modifications have profound functional consequences for siRNA efficacy in vivo. Consequently, this strategy has potential implications for therapeutic intervention in IBD and other diseases.

SUBMITTER: Ocampo SM 

PROVIDER: S-EPMC3277229 | biostudies-literature | 2012 Feb

REPOSITORIES: biostudies-literature

altmetric image

Publications

Functionally enhanced siRNA targeting TNFα attenuates DSS-induced colitis and TLR-mediated immunostimulation in mice.

Ocampo Sandra M SM   Romero Carolina C   Aviñó Anna A   Burgueño Joan J   Gassull Miguel A MA   Bermúdez Jordi J   Eritja Ramon R   Fernandez Ester E   Perales Jose C JC  

Molecular therapy : the journal of the American Society of Gene Therapy 20111101 2


Tumor necrosis factor (TNFα) is a proinflammatory cytokine involved in the pathogenesis of inflammatory bowel disease (IBD). Although TNFα has been extensively targeted using systemic drugs, the use of antisense and small interfering RNA (siRNA) to drive down its expression at the site of inflammation should provide important advantages. In this study, native and chemically modified siRNA against TNFα was developed and characterized using a murine model of IBD. siRNA with 2'-O-methyl and propane  ...[more]

Similar Datasets

| S-EPMC6642284 | biostudies-literature
| S-EPMC4893119 | biostudies-literature
| S-EPMC9877450 | biostudies-literature
| S-EPMC3855152 | biostudies-literature
| S-EPMC8908134 | biostudies-literature
| S-EPMC4661522 | biostudies-literature
| S-EPMC8098793 | biostudies-literature
| S-EPMC9649634 | biostudies-literature
| S-EPMC7985669 | biostudies-literature
| S-EPMC4100604 | biostudies-literature